Demystifying Targeted Cancer Treatments
Duration 5 weeks
Weekly study 3 hours
Extra benefits From $74 Find out more
Deepen your understanding and improve communication with patients and colleagues
New from February 2020: The world of cancer treatment is changing rapidly, therefore we’ve added new content on immunotherapies, such as checkpoint inhibitors, CAR T cells, PARP inhibitors and CDK inhibitors.
Although the course is open to all, it has been designed primarily for clinical research nurses working with patients on clinical cancer trials, along with clinical cancer research staff and specialist cancer nurses. See more information below.
Thanks to ground-breaking research over the past 20 years, new, more targeted treatments and immunotherapies have been developed that are changing the way we treat cancer, and providing new hope for patients. Join us and discover the science behind these treatments and learn through quizzes, interviews, articles and patient case studies. Each week you’ll have the opportunity to engage in discussion with other learners on key issues. You’ll learn from experts in the field and gain a deeper understanding of how targeted cancer treatments and immunotherapies work to support your patients.
What topics will you cover?
- What are targeted treatments and how are they used today
- Biological concepts behind targeted cancer treatments and immunotherapies
- Principles of cell communication and cancer
- Treatments for solid tumours that block cell communication pathways (monoclonal antibodies and kinase inhibitors)
- Communicating to patients about targeted cancer treatments
- Side effects of treatments and how they impact patients’ quality of life
- The unique properties of blood cancers and the targeted therapies used to treat them
- The relationship between cancer and the immune system
- Various immunotherapy strategies including checkpoint inhibitors, CAR-modified T cells and cancer treatment vaccines
- How immunotherapy is reported in the news and managing patient expectations of treatment
- The challenges of drug resistance and the implementation of biomarker tests
- The future of targeted cancer treatments
When would you like to start?
Most FutureLearn courses run multiple times. Every run of a course has a set start date but you can join it and work through it after it starts. Find out more
Who is the course for?
This course has been designed primarily for clinical cancer research nurses, along with other members of the clinical cancer research team. It can go towards your Continuing Professional Development (CPD) and/or revalidation with the Nursing and Midwifery Council.
The course is also relevant for and may be of interest to specialist cancer nurses and other health professionals including pharmacists and medical/science graduates studying this topic.
A basic understanding of how cells work is needed to get the most out of this course. Some experience working in cancer is also recommended.
Who will you learn with?
Join this course
Join free and you will get:
Upgrade this course and you will get:
for one year
Buy Unlimited and you will get:
Do you know someone who’d love this course? Tell them about it...
You can use the hashtag #FLCancerTreatments to talk about this course on social media.